- Year: 2021
- December 09, 2021
Company Launches Domestic Oncology Marketing
MEDICAMEN has officially initiated domestic oncology marketing, aimed at raising awareness and promoting its range of oncology products. This strategy is designed to enhance the visibility of the company’s offerings in the oncology sector and to engage healthcare professionals and patients effectively.
- Year: 2021
- January 13, 2021
Company Advances in Regulatory Compliance with Filing of US DMFs and CEPs for APIs
The company has made significant strides in regulatory compliance by filing Drug Master Files (DMFs) with the U.S. Food and Drug Administration (FDA) and Certificates of Suitability (CEPs) with the European Directorate for the Quality of Medicines (EDQM) for its Active Pharmaceutical Ingredients (APIs).
- Year: 2021
- February 17, 2021
Operations Commence at Haridwar Formulation Unit II (FDF) for Oncology
The Haridwar Formulation Unit II, specializing in Finished Dosage Forms (FDF) for oncology, has officially begun operations. This new facility is set to enhance the production of critical oncology medications, reinforcing the company's commitment to providing high-quality pharmaceutical solutions for cancer treatment.
Recent Posts
